Estimated Prevalence and Number of PiMZ Genotypes of Alpha-1 Antitrypsin in Seventy-Four Countries Worldwide

References

• Miravitlles M, Dirksen A, Ferrarotti I, et al. European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. Eur Respir J. 2017;50:1700610.
   PubMed Web of Science ®Google Scholar
• Seixas S, Marques PI. Known mutations at the cause of Alpha-1 antitrypsin deficiency an updated overview of SERPINA1 variation spectrum. Appl Clin Genet. 2021;14:173–194.
   PubMed Web of Science ®Google Scholar
• de Serres F, Blanco I. Role of alpha-1 antitrypsin in human health and disease. J Intern Med. 2014;276:311–335.
   PubMed Web of Science ®Google Scholar
• Stoller JK, Hupertz V, Aboussouan LS. Alpha-1 antitrypsin deficiency. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews®. Seattle: University of Washington, Seattle; 2006:1993–2020.
   Google Scholar
• Lomas DA, Evans DL, Finch JT, Carrell RW. The mechanism of Z α1 antitrypsin accumulation in the liver. Nature. 1992;357:605–607.
   PubMed Web of Science ®Google Scholar
• Strnad P, McElvaney NG, Lomas DA. Alpha(1)-antitrypsin deficiency. N Engl J Med. 2020;382:1443–1455.
   PubMed Web of Science ®Google Scholar
• Laurell CB, Eriksson S. The electrophoretic alpha1-globulin pattern of serum in alpha1-antitrypsin deficiency. Scan J Clin Lab Invest. 1963;15:132–140.
   Web of Science ®Google Scholar
• Fagerhol MK, Hauge HE. Serum Pi types in patients with pulmonary disease. Acta Allergol. 1969;24:107–109.
   PubMedGoogle Scholar
• Welch MH, Reinecke ME, Hammarsten JF, Guenter CA. -1 antitrypsin deficiency in pulmonary disease; the significance of intermediate levels. Ann Intern Med. 1969;71:533–537.
   PubMed Web of Science ®Google Scholar
• Talamo RC, Langley CE, Levine BW, Kazemi H. Genetic vs. quantitative analysis of serum −1 antitrypsin. N Engl J Med. 1972;287:1067–1069.
   PubMed Web of Science ®Google Scholar
• Gerblich AA, Kleinerman J, Rynbrandt DJ, Chester EH, Ihrig J. Pi-Z phenotypes in a pulmonary clinic: their prevalence and physiologic state. Am J Clin Pathol. 1978;69:509–513.
   PubMed Web of Science ®Google Scholar
• Kueppers F, Donhardt A. Obstructive lung disease in heterozygotes for −1 antitrypsin deficiency. Ann Intern Med. 1974;80:209–212.
   PubMed Web of Science ®Google Scholar
• Mittman C, Lieberman J, Rumsfeld J. Prevalence of abnormal protease inhibitor phenotypes in patients with chronic obstructive lung disease. Am Rev Respir Dis. 1974;109:295–296.
   PubMedGoogle Scholar
• Barnett TB, Gottovi D, Johnson AM. Protease inhibitors in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1975;111:587–593.
   PubMedGoogle Scholar
• Cox DW, Hoeppner VH, Levison H. Protease inhibitors in patients with chronic obstructive pulmonary disease: the a-1 antitrypsin heterozygote controversy. Am Rev Respir Dis. 1976;113:601–606.
   PubMed Web of Science ®Google Scholar
• Shigeoka JW, Hall WJ, Hyde RW, et al. The prevalence of α-1 antitrypsin heterozygotes (PiMZ) in patients with obstructive pulmonary disease. Am Rev Respir Dis. 1976;114:1077–1084.
   PubMed Web of Science ®Google Scholar
• Lochon BDV, Lochon C, Fournier M, Martin JP, Derenne JP, Pariente R. Pan-lobular emphysema: relationship with serum α-1 antitrypsin levels, Pi phenotype and the HLA system. Nouv Presse Med. 1978;7:1167–1170.
   PubMedGoogle Scholar
• Stockley RA. Alpha-1-antitrypsin phenotypes in cor pulmonale due to chronic obstructive airways disease. Q J Med. 1979;48:419–428.
   PubMedGoogle Scholar
• Bruce RM, Cohen BH, Diamond EL, et al. Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects. Am Rev Respir Dis. 1984;130:386–390.
   PubMedGoogle Scholar
• Bartmann K, Fooke-Achterrath M, Koch G, et al. Heterozygosity in the Pi-system as a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD). Eur J Respir Dis. 1985;66:284–296.
   PubMedGoogle Scholar
• Klasen EC, Biemond I, Laros CD. α-1 antitrypsin deficiency and the flaccid lung syndrome: the heterozygote controversy. Clin Genet. 1986;29:211–215.
   PubMed Web of Science ®Google Scholar
• Lieberman J, Winter B, Sastre A. α-1 antitrypsin Pi-types in 965 COPD patients. Chest. 1986;89:370–373.
   PubMed Web of Science ®Google Scholar
• Hersh CP, Dahl M, Ly NP, Berkey CS, Nordestgaard BG, Silverman EK. Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis. Thorax. 2004;59:843–849.
   PubMed Web of Science ®Google Scholar
• Sørheim IC, Bakke P, Gulsvik A, et al. α1-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. Chest. 2010;138:1125–1132.
   PubMed Web of Science ®Google Scholar
• Molloy K, Hersh CP, Morris VB, et al. Clarification of the risk of chronic obstructive pulmonary disease in alpha-1 antitrypsin deficiency PiMZ heterozygotes. Am J Respir Crit Care Med. 2014;189:419–427.
   PubMed Web of Science ®Google Scholar
• Foreman MG, Wilson C, DeMeo DL, et al. Alpha-1 antitrypsin PiMZ genotype is associated with chronic obstructive pulmonary disease in two racial groups. Ann Am Thorac Soc. 2017;14:1280–1287.
   PubMed Web of Science ®Google Scholar
• Al Ashry HS, Strange C. COPD in individuals with the PiMZ alpha-1 antitrypsin genotype. Eur Respir Rev. 2017;26:170068.
   PubMed Web of Science ®Google Scholar
• Pittschieler K. Liver involvement in alpha-1 antitrypsin-deficient phenotypes PiSZ and PiMZ. Acta Paediatr. 2002;91:239–240.
   PubMed Web of Science ®Google Scholar
• Graziadei IW, Joseph JJ, Wiesner RH, Therneau TM, Batts KP, Porayko MK. Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency. Hepatology. 1998;28:1058–1063.
   PubMed Web of Science ®Google Scholar
• Schaefer B, Mandorfer M, Viveiros A, et al. Heterozygosity for the alpha-1-antitrypsin Z allele in cirrhosis is associated with more advanced disease. Liver Transpl. 2018;24:744–751.
   PubMed Web of Science ®Google Scholar
• Strnad P, Buch S, Hamesch K, et al. Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis. Gut. 2019;68:1099–1107.
   PubMed Web of Science ®Google Scholar
• Shah RS, Alsuleiman B, Bena J, Stoller JK, Wakim-Fleming J. Alpha-1 antitrypsin deficiency is under-recognized in individuals with cirrhosis undergoing liver transplantation. Eur J Gastroenterol Hepatol. 2020. doi:10.1097/MEG.0000000000002005
   Web of Science ®Google Scholar
• de Serres FJ. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest. 2002;122:1818–1829.
   PubMed Web of Science ®Google Scholar
• Blanco I, Bueno P, Diego I, et al. Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update. Int J Chron Obstruct Pulmon Dis. 2017;12:561–569.
   PubMed Web of Science ®Google Scholar
• Blanco I, Bueno P, Diego I, et al. Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide. Int J Chron Obstruct Pulmon Dis. 2017;12:1683–1694.
   PubMed Web of Science ®Google Scholar
• Blanco I, Diego I, Bueno P, Pérez-Holanda S, Casas-Maldonado F, Miravitlles M. Prevalence of α1-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review. Eur Respir Rev. 2020;29:200014.
   PubMed Web of Science ®Google Scholar
• Chan-Yeung M, Ashley MJ, Corey P, Maledy H. Pi phenotypes and the prevalence of chest symptoms and lung function abnormalities in workers employed in dusty industries. Am Rev Respir Dis. 1978;117:239–245.
   PubMedGoogle Scholar
• Beckman G, Beckman L, Mikaelsson B, Rudolphi O, Stjernberg N, Wiman LG. Alpha-1-antitrypsin types and chronic obstructive lung disease in an industrial community in Northern Sweden. Hum Hered. 1980;30:299–306.
   PubMed Web of Science ®Google Scholar
• Banauch GI, Brantly M, Izbicki G, et al. Accelerated spirometric decline in New York City firefighters with α1-antitrypsin deficiency. Chest. 2010;138:1116–1124.
   PubMed Web of Science ®Google Scholar
• Mehta AJ, Thun GA, Imboden M, et al. Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline. Occup Environ Med. 2014;71:234–240.
   PubMed Web of Science ®Google Scholar
• Pons M, Nuñez A, Esquinas C, et al. Utility of transient elastography for screening of liver disease in patients with alpha1-antitrypsin deficiency. J Clin Med. 2021;10:1724.
   PubMed Web of Science ®Google Scholar
• Barjaktarevic I, Miravitlles M. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis. BMC Pulm Med. 2021;21:99.
   PubMed Web of Science ®Google Scholar
• Blanco I. A well-designed/conducted study on alpha-1 antitrypsin epidemiology not quoted. Eur Respir J. 2018;51:1702662.
   PubMed Web of Science ®Google Scholar
• Pathak U, Gupta NC, Suri JC. Risk of COPD due to indoor air pollution from biomass cooking fuel: a systematic review and meta-analysis. Int J Environ Health Res. 2020;30:75–88.
   PubMed Web of Science ®Google Scholar
• Holm KE, Mannino DM, Choate R, Sandhaus RA. Genotype is associated with smoking and other key health behaviors among individuals with alpha-1 antitrypsin deficiency-associated lung disease. Respir Med. 2018;143:48–55.
   PubMed Web of Science ®Google Scholar
• Franciosi AN, Alkhunaizi MA, Woodsmith A, et al. Alpha-1 antitrypsin deficiency and tobacco smoking: exploring risk factors and smoking cessation in a registry population. COPD. 2021;18(1):76–82.
   PubMedGoogle Scholar
• Crystal RG. Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J Clin Invest. 1990;85:1343–1352.
   PubMed Web of Science ®Google Scholar
• Bornhorst JA, Greene DN, Ashwood ER, Grenache DG. Alpha1-antitrypsin phenotypes and associated serum protein concentrations in a large clinical population. Chest. 2013;143:1000–1008.
   PubMed Web of Science ®Google Scholar
• Ferrarotti I, Thun GA, Zorzetto M, et al. Serum levels and genotype distribution of alpha1-antitrypsin in the general population. Thorax. 2012;67:669–674.
   PubMed Web of Science ®Google Scholar
• Strange C, Monk R, Schwarz L, Walker D, Kumbhare S, Bieko T. The United States Alpha-1 foundation research registry: genesis, impact and future. COPD. 2015;12(Suppl 1):42–45.
   PubMedGoogle Scholar
• Donato LJ, Karras RM, Katzmann JA, Murray DL, Snyder MR. Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency alleles. Respir Res. 2015;16:96.
   PubMed Web of Science ®Google Scholar
• Alam S, Li Z, Atkinson C, Jonigk D, Janciauskiene S, Mahadeva R. Z α1-antitrypsin confers a proinflammatory phenotype that contributes to chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189:909–931.
   PubMed Web of Science ®Google Scholar
• Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Köhnlein T, Welte T. The discovery of α1-antitrypsin and its role in health and disease. Respir Med. 2011;105:1129–1139.
   PubMed Web of Science ®Google Scholar
• Ellis P, Turner A. What do Alpha-1 antitrypsin levels tell us about chronic inflammation in COPD? Arch Bronconeumol. 2020;56(2):72–73.
   PubMed Web of Science ®Google Scholar
• Janciauskiene S, DeLuca DS, Barrecheguren M, Welte T, Miravitlles M. Serum levels of Alpha1-antitrypsin and their relationship with COPD in the General Spanish Population. Arch Bronconeumol. 2020;56:76–83.
   PubMed Web of Science ®Google Scholar
• Matamala N, Lara B, Gómez-Mariano G, et al. miR-320c regulates SERPINA1 expression and is induced in patients with pulmonary disease. Arch Bronconeumol. 2021;57(4):457–463.
   PubMedGoogle Scholar
• Matamala N, Lara B, Gomez-Mariano G, et al. Characterization of novel missense variants of SERPINA1 gene causing Alpha-1 antitrypsin deficiency. Am J Respir Cell Mol Biol. 2018;58:706–716.
   PubMed Web of Science ®Google Scholar
• Martin T, Miravitlles M, Tello Furtado S. A PI*MS is not always a PI*MS. An example of when genotyping for alpha-1 antitrypsin deficiency is necessary. Pulmonology. 2021;27:257–276.
   PubMed Web of Science ®Google Scholar
• Foil KE, Blanton MG, Sanders C, et al. Sequencing Alpha-1 MZ individuals shows frequent biallelic mutations. Pulm Med. 2018;2018:2836389.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Nuñez A, Torres-Durán M, et al. The importance of reference centers and registries for rare diseases: the example of Alpha-1 antitrypsin deficiency. COPD. 2020;17(4):346–354.
   PubMedGoogle Scholar